医学
入射(几何)
置信区间
人口
人类免疫缺陷病毒(HIV)
暴露前预防
变性妇女
恩曲他滨
内科学
和男人发生性关系的男人
比率
随机对照试验
抗逆转录病毒疗法
免疫学
病毒载量
梅毒
物理
环境卫生
光学
作者
Colleen F. Kelley,Maribel Acevedo-Quiñones,Allison L. Agwu,Anchalee Avihingsanon,Paul Benson,Jill Blumenthal,Cynthia Brinson,Carlos Brites,Pedro Cahn,Valeria D. Cantos,Jesse L. Clark,Meredith E. Clement,Catherine Creticos,Gordon Crofoot,Ricardo Sobhie Diaz,Susanne Doblecki‐Lewis,Jorge A. Gallardo-Cartagena,Aditya H. Gaur,Beatriz Grinsztejn,Shawn Hassler
标识
DOI:10.1056/nejmoa2411858
摘要
The HIV incidence with twice-yearly lenacapavir was significantly lower than the background incidence and the incidence with F/TDF. (Funded by Gilead Sciences; PURPOSE 2 ClinicalTrials.gov number, NCT04925752.).
科研通智能强力驱动
Strongly Powered by AbleSci AI